Form D · Biotechnology
SERNOVA CORP.
London, A6 · CIK 0001491434
Offering snapshot reported Sep 11, 2024 · SEC filing
- Reported sold
- $473K Offering amount: $1.04M
- Investors reported
- 2 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 3, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 11, 2024 | Initial | $473,128 | No comparison | 2 | SEC filing |
| Oct 6, 2020 | Initial | $19,158 | No comparison | 1 | SEC filing |
| Sep 9, 2019 | Initial | $100,343 | No comparison | 1 | SEC filing |
| Jul 13, 2016 | Initial | $10,570 | No comparison | 1 | SEC filing |
| Apr 5, 2012 | Initial | $85,077 | No comparison | 1 | SEC filing |
| Jun 8, 2010 | Initial | $19,570 | No comparison | 1 | SEC filing |
| May 10, 2010 | Initial | $29,621 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-523761
Total Offering Amount represents the aggregate price of Units (1,397,100 x C$0.25) plus the aggregate exercise price of the underlying warrants (1,397,100 x C$0.30). Conversion rate C$1:US$1.3546. There is no guarantee that the warrants will be exercised.
Source: Form D, filed Sep 11, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| George Adams | Director |
| Jeffrey Bacha | Director |
| Jeffrey A. Bacha | Director |
| Deborah M. Brown | Director |
| Ralph Deiterding | Executive |
| Sean Hodgins | Executive |
| Frank A. Holler | Director |
| Frank Holler | Director |
| Hans Mader | Director |
| Annemarie Moseley | Director |
| Bernd Muehlenweg | Director |
| Modestus Obochi | Executive |
| James T. Parsons | Director |
| Jonathan Rigby | Director, Executive |
| Nicholas Rossettos | Executive |
| Steven Sangha | Director |
| G. William Smethurst | Executive |
| David Swetlow | Executive |
| Philip Toleikis | Director, Executive |
| Bruce Weber | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
700 Collip Circle, Suite 114
London, A6, N6G 4X8
London, A6, N6G 4X8